SR One Capital Management, LP
Source: SEC Form 13F · as of Mar 2026SR One Capital Management, LP holds 5 biotech & pharma companies tracked by BioSniper, totaling $379.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
5
Total value held
$379.0M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Arcellx, Inc. (ACLX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ACLXArcellx, Inc. | 2,346,630 | $269.4M |
| ALMSALUMIS INC. | 1,959,896 | $43.2M |
| MLYSMineralys Therapeutics, Inc. | 1,563,966 | $42.4M |
| ORKAOruka Therapeutics, Inc. | 430,330 | $21.1M |
| RAREUltragenyx Pharmaceutical Inc. | 137,753 | $2.9M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.